Searched for
PATIENT ACCESS TO TREATMENTS
Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...- His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccinesHyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technol...
- The business of running a hospital: Balancing profitability, patient trust and scaleA hospital’s financial health depends on more than occupancy and revenue, requiring a careful balance of cost control, cash flow and patien...
- ET Product of the Year Awards 2026: Categories recognising products driving market impactThe Economic Times Product of the Year Awards 2026 celebrate cutting-edge innovations that make a substantial difference in the market and ...
- Frontline Workers Know How to Solve Your Organization’s Biggest ProblemsFrontline employees often know exactly what’s preventing organizations from performing at their best, yet traditional engagement surveys ra...
- Assam signs Rs 600 crore deal for India's first state-run proton therapy centreThe Government of Assam has signed an agreement with IBA Particle Therapy India Pvt. Ltd. to establish a Proton Beam Therapy Centre. This f...
- AIIMS Gorakhpur director shifted to private hospital for heart-related evaluation; institute says advanced cardiac care facility to be operational soonAIIMS Gorakhpur Executive Director Major General (retd) Vibha Dutta was shifted to a private hospital for cardiac evaluation after developi...
- NPPA list brings little relief: No price cut for 25% cancer drugsNearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across ...
- India’s drug pricing policy must balance affordability, medicine availability and pharma industry growthThe Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...
- Anti-cancer medicines: How to protect the patient today without weakening India's healthcare capacity for tomorrowIndia should examine trade margins across medicines, medical devices and consumables using a common, scientifically credible method - not a...
- Rs 1 lakh to Rs 30,000: Cancer immunotherapy gets cheaper, but will patients get the price benefit?Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...
- YC-backed healthtech startup BioStack raises $9.5 million from Peak XV, DCVC, othersThe Y Combinator-backed startup, which operates across India, the US, Brazil and Argentina, has access to more than 100 million de-identifi...
- NYC woman announced her death at 38, helped erase $44.9 million in medical debt for 51,000 people across 9 statesA 38-year-old New York City mother Casey Ryan McIntyre battling ovarian cancer arranged to erase $44.9 million in medical debt affecting 51...
- Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trialJohnson & Johnson reported results from an early-stage trial of their prostate cancer drug JNJ-6143. The trial involved patients with advan...
- VIP culture in hospitals can compromise patient safety, equitable care: AIIMS doctorsAIIMS Delhi doctors discuss the ethical challenges posed by preferential treatment for VIP patients in healthcare. They emphasize that such...
- GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan saysThe China-India-Brazil market for GLP-1 weight-loss drugs could expand to $22 billion by 2035 from $6.6 billion currently, J.P. Morgan esti...
- From Continuous Data to Trusted Health Intelligence: What Abu Dhabi and India Can Learn From Each Other About Predictive Health?Predictive health will depend not on how much data health systems collect, but on whether they can validate it, govern it responsibly, and ...
- Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in IndiaSanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...
- Dr Reddy's gets DCGI nod for Zytorvi in advanced esophageal cancerDr Reddy's Laboratories has received approval for Zytorvi, an immunotherapy targeting advanced esophageal squamous cell carcinoma. This new...
- HealthRail: Turning India's hospital receivables into growth capitalIn a strategic move to streamline hospital cash flow, HealthRail is offering expedited access to accrued revenues. This initiative specific...
Load More
